Stockreport

Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Elicio Therapeutics, Inc.  (ELTX) 
PDF BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developin [Read more]